SEC Form 4 · accession 0000950142-17-001960
CDK Global, Inc. · CDK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer A. Williams
Officer — VP, Corporate Controller & CAO
Period of report
Nov 2, 2017
Accepted (ET)
Nov 6, 2017 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609702
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2017 | M | 1,277 | $30.13 | A | 5,560 | D | |
| Common StockF1 | Nov 2, 2017 | S | 1,984 | $62.579 | D | 3,576 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $30.13 | Nov 2, 2017 | M | 1,277 | D | — | Sep 30, 2024 | Common Stock | 1,277 | 1,278 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple open market transactions at prices ranging from $62.453 to $62.670, inclusive. The report person undertakes to provide to CDK Global, Inc., a security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
- F2Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.